The effects of hepatic disease on the pharmacokinetics of the histamine H2-receptor antagonist famotidine were studied in seven healthy volunteers and 20 patients with chronic liver disease. ... Thus, famotidine had no effect on hepatic hemodynamics or function in healthy subjects and patients with chronic liver disease.
